Work

Su1840: RO7790121 SHOWS EARLY AND RAPID SYMPTOMATIC REMISSION IN THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS – FINDINGS FROM THE PHASE IIB TUSCANY-2 TRIAL